Transwell assays further validated that co-overexpression of ATG7 reversed the phenotypic changes induced by MiR-582-5p overexpression in gastric cancer cells, including their sensitivity to oxaliplatin (Figures 7C–E). This evidence concerns the gene ATG7 and gastric cancer.